All News

IL-6 IL6 cells cytokine

NEJM: Interleukin-6 Inhibition in Critically-Ill COVID-19

d Jack Cush, MD

The pendulum and jury are wavering with regard to the benefits of interleukin-6 receptor antagonists in COVID-19; the current NEJM reports the results of a study favoring such biologic therapy in in critically ill COVID-19 patients.

Read Article
Lumbar rash DM

MAXIMISE Trial - Secukinumab Efficacy in Psoriatic Spondylitis Patients

d Jack Cush, MD

The results of the novel MAXIMISE trial have been published, demonstrating that secukinumab significantly improved axial signs and symptoms in psoriatic arthritis patients with axial manifestations with inadequate NSAID response.

Read Article
Report from DANBIO Danish register looked at chronic pain in a matched cohort study of Psoriasis. Chronic pain was not associated with excess mortality (hence not PsA) (OR 0.99,0.95-1.03). Mortality was increased with steriods, COPD, DM, CA, CV disease.  https://t.co/91JW3BOPtw

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: NEJM: Interleukin-6 Inhibition in Critically-Ill COVID-19 https://t.co/IrKnTlPDpK https://t.co/8topsI3nQN

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Self-Medicating Myself Getting pills from Mexico, Spouse or the Dog? https://t.co/jcAmyhihN5 https://t.co/68UMEVCM6W

Links:

Dr. John Cush RheumNow ( View Tweet)
Top February Tweet: ACR Task Force published guidelines on RMD drug use w/ COVID vaccines. My views: 1. I agree, no change most DMARD, biologics 2. I disagree; I would NOT hold Orencia, I would NOT hold JAKi 3. I disagree: I would not hold MTX https://t.co/uSPfvJB8EC https://t.co/unOY1jvzTJ

Links:

Dr. John Cush RheumNow ( View Tweet)
Compared with no statin use; statin use in RA pts is assoc w/ 28% lower mortality risk. Population study of 19,614 RA pts w/ incident statin use, compared 1,883 statin users vs 1,883 nonusers. All-cause mortality was lower (HR 0.72;0.56-0.91) w/ statins https://t.co/onMlWoVdPL

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Measureable Benefits to Treat-to-Target Management in RA https://t.co/iAvLWJGTXp https://t.co/NfNj3MWznI

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. The speaker list includes: Roy Fleischmann, Alan Matsumoto, Clay Cockerell, Eric Ruderman, Alexis Ogdie, Philip Robinson, Jeff Sparks, and more. https://t.co/vJlU0Z3Q3x https://t.co/fRbQbGRwoR

Links:

Dr. John Cush RheumNow ( View Tweet)
Pooled analysis of 16 observational RA registries (27 583 patients) shows that seropositivity was associated with better remission, LDAS and withdrawal rates for RTX and ABA, but not TNF inhibitors. https://t.co/aNphJpB7JB

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic: PFAPA Syndrome Recurrent Fevers, Stomatitis, Lymphadenopathy ? https://t.co/uMBk8e2wJO https://t.co/02ZMjRmOuU

Links:

Dr. John Cush RheumNow ( View Tweet)
Systemic Sclerosis is 5 times more prevalent in women than men. Analysis of epidemiology studies shows SSc prevalence as 17.6 per 100000 and pooled incidence of SSc was 1.4 per 100000 PYs. https://t.co/RyVIBUWyen

Links:

Dr. John Cush RheumNow ( View Tweet)

Its sill not SAFE! Avoid congregate settings! CDC report shows among 81 who participated in indoor high-intensity exercise classes - 68% developed COVID-19. 40% with COVID-19 attended class on day Sxs began. Most (76%) wore masks infrequently https://t.co/KLZauJUupN

Links:

Dr. John Cush RheumNow ( View Tweet)

In Israel (as of Feb 2021) 84% of those ≥70 years and 10% for <50 years have received 2 doses of the COVID Vaccine; as such the need for mechanical ventilation in the elderly has declined 67% with the implementation of COVID vaccines. https://t.co/9Qnv72QYUS

Links:

Dr. John Cush RheumNow ( View Tweet)

Listen to last weeks QD Clinics Podcasts (134-137 Feb 26) - RA or Not QD137 - RA or Not QD136 - Periorbital Mass QD135 - Periorbital Edema QD134 - PFAPA Syndrome https://t.co/pMXm6vFuBl

Links:

Dr. John Cush RheumNow ( View Tweet)

My Experience as a COVID19 Vaccine Trial Participant https://t.co/ILfXLUL8IZ

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - RA or Not? Lessons from the clinic. Enough serology, but not enough joints - when does it become RA? https://t.co/akklOklPee

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: MAXIMISE Trial - Secukinumab Efficacy in Psoriatic Spondylitis Patients https://t.co/34RU4OSaRi

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Higher Lupus Mortality Among Minority Populations https://t.co/l4xUz9se02 https://t.co/UsGRc2twWU

Links:

Dr. John Cush RheumNow ( View Tweet)
We are three weeks out from RheumNow Live. Are you planning on attending? https://t.co/vJlU0Z3Q3x

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×